Nexa3D has confirmed $55m in funding across several rounds, while BukuKas has added $50m to its coffers and both Label Insights and Mya Systems have been acquired.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Bright Machines highlights reverse merger
SoftBank is participating in a PIPE financing for Flex spinoff Bright Machines, which will walk away with $435m in gross proceeds and a $1.1bn valuation.
Back Market sells investors on $335m series D
Aglaé Ventures and Goldman Sachs returned for a $335m series D round for Back Market, having already participated in a $120m series C a year ago.
Interius initiates $76m series A
Pfizer Ventures and Penn Medicine both contributed to an oversubscribed series A round for University of Pennslyvania spinout Interius Biotherapeutics.
How Evox is engineering a new class of therapeutics
Spinouts always operate, by their very nature, on the cutting edge of science, but every once in a while, one comes along that could prove truly transformational by inventing an entirely new field.
Daily Deal Round Up: May 17, 2021
Vark and Willbox have both raised funding, while Cisco has decided to buy Kenna Security and Guru Capital has purchased Oval Money.
Gojek goes to Tokopedia for $18bn merger
Just days after Telkomsel injected $300m into Gojek, the company has finalised its merger with Tokopedia to form a new business called GoTo that will go public this year.
JD Logistics gears up for $3.4bn IPO
The logistics services provider has set a price range for its proposed offering and will raise up to $3.4bn in proceeds, with JD.com retaining a majority stake.
Pine Labs picks investors for $285m
Mastercard and PayPal-backed fintech developer Pine Labs has collected $285m in primary and secondary financing.
TwinStrand takes in $50m
Genetic sequencing platform developer TwinStrand has secured $50m in a series B round led by Section 32, while Alexandria Venture Investments invested for a third time.
BeLab1407 brings $20m to UK universities
Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.
Inivata inspires $390m acquisition
NeoGenomics has agreed to buy portfolio company Inivata, a liquid biopsy platform developer, a year after it invested $25m.
Vaccitech accesses public markets
GV, Tencent and Gilead Sciences will exit the vaccine and infectious disease drug developer in an initial public offering sized at about $110m.
Gyroscope turns to Fosun for $148m round
Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.